NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1.
暂无分享,去创建一个
M. Minden | E. Atenafu | J. Capo-Chichi | A. Schuh | A. Tierens | Adam C. Smith | Entsar Eladl | Hong Chang | Davidson Zhao | Mojgan Zarif